Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 442.75
-11.10 (-2.45%)
Oct 23, 2026, 12:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 169.39 billion as of October 22, 2026. It is the 6,935th most valuable company in the world and the 393rd biggest in India. Its market cap has decreased by 50.71% in one year.
Market Cap
169.39B
Enterprise Value
171.37B
Revenue
21.42B
Global Rank
Country Rank
#393 India
PE Ratio
163.46
ChartMarket Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 169.39B, an increase of 502,481.12%. That is a compound annual growth rate of 261.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 169.39B | -16.23% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 335.09B |
| Wockhardt | 309.76B |
| Piramal Pharma | 258.46B |
| Alivus Life Sciences | 155.71B |
| Eris Lifesciences | 155.44B |
| Alembic Pharmaceuticals | 155.35B |
| NATCO Pharma | 143.44B |
| Sudeep Pharma | 113.32B |